GO Pharma Consulting Ltd., Welwyn AL6 0QT, United Kingdom.
Department of Neuroscience, Cell Biology and Anatomy, University of Texas Medical Branch, Galveston, TX 77555; and.
J Immunol. 2020 Nov 15;205(10):2726-2741. doi: 10.4049/jimmunol.2000803. Epub 2020 Oct 9.
HIV has become a chronic disease despite the effective use of antiretroviral therapy (ART). However, the mechanisms of tissue colonization, viral evolution, generation of viral reservoirs, and compartmentalization are still a matter of debate due to the challenges involved in examining early events of infection at the cellular and molecular level. Thus, there is still an urgent need to explore these areas to develop effective HIV cure strategies. In this study, we describe the early events of tissue colonization and compartmentalization as well as the role of tunneling nanotube-like structures during viral spread in the presence and absence of effective antiretroviral treatment. To examine these mechanisms, NOD/SCID IL-2 RG humanized mice were either directly infected with HIV or with low numbers of HIV-infected leukocytes to limit tissue colonization in the presence and absence of TAK779, an effective CCR5 blocker of HIV entry. We identify that viral seeding in tissues occurs early in a tissue- and cell type-specific manner (24-72 h). Reduction in systemic HIV replication by TAK779 treatment did not affect tissue seeding or spreading, despite reduced systemic viral replication. Tissue-associated HIV-infected cells had different properties than cells in the circulation because the virus continues to spread in tissues in a tunneling nanotube-like structure-dependent manner, despite ART. Thus, understanding these mechanisms can provide new approaches to enhance the efficacy of existing ART and HIV infection cure strategies.
尽管抗逆转录病毒疗法(ART)的应用非常有效,但 HIV 仍然是一种慢性疾病。然而,由于在细胞和分子水平上检查感染早期事件存在挑战,组织定植、病毒进化、病毒储存库的产生和区室化的机制仍然存在争议。因此,仍然迫切需要探索这些领域,以开发有效的 HIV 治愈策略。在这项研究中,我们描述了组织定植和区室化的早期事件,以及在存在和不存在有效抗逆转录病毒治疗的情况下,隧道纳米管样结构在病毒传播中的作用。为了研究这些机制,我们使用 NOD/SCID IL-2RG 人源化小鼠直接感染 HIV 或感染少量 HIV 感染的白细胞,以限制组织定植的发生,同时使用 TAK779,一种有效的 HIV 进入抑制剂。我们发现,病毒在组织中的播种发生在组织和细胞类型特异性的早期(24-72 小时)。尽管系统中的 HIV 复制减少,但 TAK779 治疗并没有影响组织播种或扩散,尽管系统中的病毒复制减少了。与循环中的细胞不同,组织相关的 HIV 感染细胞具有不同的特性,因为尽管存在抗逆转录病毒治疗,病毒仍以隧道纳米管样结构依赖的方式继续在组织中传播。因此,了解这些机制可以为提高现有抗逆转录病毒治疗和 HIV 感染治愈策略的疗效提供新的方法。